Omitting endocrine therapy in ER-low breast cancer was associated with a 23% relative increase in the risk of death in 3 ...

Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ ...

Fengting Yan, MD, PhD, discusses how her clinical practice is informed by data and guidelines available on testing in breast cancer.

For metastatic breast cancer patients, care doesn't stop at the doctor's office. Learn from our experts on how to build your ...

Capivasertib is used to treat incurable breast cancer and has shown to have slowed the disease down. The twice-a-day pill, which is for the most common type of advanced breast can ...